Shattuck Labs (NASDAQ:STTK) Sees Large Volume Increase dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Shattuck Labs to Present Additional Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients at the European Hematology Association (EHA) 2024 Congress marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Shattuck Labs to Present Additional Data from the Phase 1B globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright reaffirmed their buy rating on shares of Shattuck Labs (NASDAQ:STTK – Free Report) in a research report released on Thursday morning, Benzinga reports. HC Wainwright currently has a $28.00 target price on the stock. Separately, Needham & Company LLC reiterated a buy rating and issued a $12.00 price objective on shares of Shattuck […]
Shattuck Labs (NASDAQ:STTK – Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($0.37) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.45) by $0.08, Briefing.com reports. Shattuck Labs had a negative net margin of 3,133.63% and a negative return on equity of 64.46%. The firm had […]